New patent expiration for Braintree drug HALFLYTELY
Annual Drug Patent Expirations for HALFLYTELY Halflytely is a drug marketed by Braintree and is included in one NDA. There is one patent protecting this drug and two Paragraph IV…
The post New patent expiration for Braintree drug HALFLYTELY appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.